Anti-tumor activity of HIS-4,a biflavonoid from Resina draconis,on human hepatoma HepG2 and SK-HEP-1 cells.
10.19540/j.cnki.cjcmm.20190218.001
- Author:
Ya-Nan ZHAO
1
;
Ai-Lin YANG
1
;
Dao-Ran PANG
1
;
Xiao-Qin SU
1
;
Xiao-Nan CHEN
1
;
Ying-Ying TIAN
1
;
Yun-Fang ZHAO
1
;
Jun LI
1
;
Peng-Fei TU
1
;
Zhong-Dong HU
1
Author Information
1. Modern Research Center for Traditional Chinese Medicine,School of Chinese Materia Medica,Beijing University of Chinese Medicine Beijing 100029,China.
- Publication Type:Journal Article
- Keywords:
HIS-4;
MAPK;
Resina draconis;
hepatocellular carcinoma;
mTOR
- MeSH:
Antineoplastic Agents, Phytogenic;
pharmacology;
Apoptosis;
Biflavonoids;
pharmacology;
Carcinoma, Hepatocellular;
drug therapy;
pathology;
Cell Movement;
Cell Proliferation;
Dracaena;
chemistry;
Hep G2 Cells;
Humans;
Liver Neoplasms;
drug therapy;
pathology;
Phytochemicals;
pharmacology
- From:
China Journal of Chinese Materia Medica
2019;44(7):1442-1449
- CountryChina
- Language:Chinese
-
Abstract:
The research of anti-hepatocellular carcinoma(HCC) drug has attracted more and more attention. Natural products are the important source of active compounds for cancer treatment. A biflavonoid HIS-4 was isolated from Resina draconis in our previous study. MTT assay, hoechst staining, and flow cytometry analysis were used to investigate the effects of HIS-4 on the proliferation and apoptosis of human hepatoma HepG2 and SK-HEP-1 cells. Moreover, the effects of HIS-4 on the migration and invasion ability of HepG2 and SK-HEP-1 cells were evaluated by wound healing assay and Transwell assay. In addition, MTT assay, flow cytometry analyses, Hoechst staining, wound healing assay, Transwell assay, and tube formation assay were used to explore the anti-angiogenic activity of HIS-4 in human umbilical vein endothelial cells(HUVECs). Mechanistically, the HIS-4 regulatory of signal pathways in H9 epG2 and SK-HEP-1 cells were analyzed by Western blot. This results showed that HIS-4 suppressed the proliferation of human hepatoma HepG2 and SK-HEP-1 cells. Moreover HIS-4 induced their apoptosis of HepG2 and SK-HEP-1 cells. HIS-4 inhibited the migration and invasion of HepG2 and SK-HEP-1 cells. Additionally, HIS-4 exhibited angiogenesis effects. Mechanistically, up-regulation of MAPK signaling pathway and down-regulation of mTOR signaling pathway may be responsible for anti-hepatoma activity of HIS-4. Therefore, HIS-4 may be a promising candidate drug for HCC treatment.
